Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid Dimethyl Ester
2. Alpha-diphenyldicarboxylate
3. Bdd
4. Biphenyl Dimethyl-dicarboxylate
5. Dimethyl 4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
6. Dimethyl Diphenyl Bicarboxylate
7. Diphenyl Dimethyl Dicarboxylate
1. 73536-69-3
2. Bifendatatum
3. Dimethyl 7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate
4. .alpha.-ddb
5. Bifendate,(s)
6. Methyl 7-methoxy-4-(7-methoxy-5-methoxycarbonyl-1,3-benzodioxol-4-yl)-1,3-benzodioxole-5-carboxylate
7. 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid Dimethyl Ester
8. Dimethyl Dicarboxylate Biphenyl
9. Diphenyl Dimethyl Bicarboxylate
10. Mfcd01751431
11. 0g32e321w1
12. Alpha-diphenyldicarboxylate
13. Biphenyl Dimethyl-dicarboxylate
14. Diphenyl Dimethyl Dicarboxylate
15. Ccris 7767
16. Brn 5461320
17. Dimethyl Diphenyl Bicarboxylate
18. Unii-0g32e321w1
19. Dimethyl 7,7'-dimethoxy-(4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylate
20. Dimethyl-4,4'-dimethoxyl-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
21. Bifendate [who-dd]
22. Dimethyl 4,4'-dimethoxy-5,6,5',6'-bis(methylenedioxy)biphenyl-2,2'-dicarboxylate
23. Schembl896166
24. Chembl105184
25. Dtxsid40223736
26. Bcp12613
27. Bdbm50289527
28. S4890
29. Zinc12153845
30. Akos015895317
31. Ccg-268865
32. Cs-w019577
33. Hy-w018791
34. Sb67338
35. (4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-, Dimethyl Ester
36. As-13115
37. Sy021274
38. B6112
39. Ft-0602821
40. 536b693
41. A866077
42. Q27236735
43. 2,2'-dimethoxycarbonyl-4,4'-dimethoxy-5,6,5',6'-bismethylenedioxybiphenyl
44. Dimethyl 7,7'-dimethoxy-4,4'-bibenzo[d][1,3]dioxole-5,5'-dicarboxylate
45. Dimethyl7,7'-dimethoxy-[4,4'-bibenzo[d][1,3]dioxole]-5,5'-dicarboxylate
46. [4,4'-bi-1,3-benzodioxole]-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-,dimethyl Ester
47. Dimethyl-4,4'-dimethoxy-5,6,5',6'-dimethylenedioxybiphenyl-2,2'-dicarboxylate
48. (4,4'-bi-1,3-benzodioxole)-5,5'-dicarboxylic Acid, 7,7'-dimethoxy-, 5,5'-dimethyl Ester
49. Dimethyl 7,7 Inverted Exclamation Mark -dimethoxy-[4,4 Inverted Exclamation Mark -bi-1,3-benzodioxole]-5,5 Inverted Exclamation Mark -dicarboxylate
| Molecular Weight | 418.3 g/mol |
|---|---|
| Molecular Formula | C20H18O10 |
| XLogP3 | 2.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 7 |
| Exact Mass | 418.08999677 g/mol |
| Monoisotopic Mass | 418.08999677 g/mol |
| Topological Polar Surface Area | 108 Ų |
| Heavy Atom Count | 30 |
| Formal Charge | 0 |
| Complexity | 587 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Adjuvants, Immunologic
Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Cytochrome P-450 Enzyme Inhibitors
Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)
Bifendate has known human metabolites that include Mono-O-demethylated bdd and methyl 4-(2,3-dihydroxy-4-methoxy-6-methoxycarbonylphenyl)-7-methoxy-1,3-benzodioxole-5-carboxylate.
S73 | METXBIODB | Metabolite Reaction Database from BioTransformer | DOI:10.5281/zenodo.4056560
Market Place
ABOUT THIS PAGE
A Bifendate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bifendate, including repackagers and relabelers. The FDA regulates Bifendate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bifendate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Bifendate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Bifendate supplier is an individual or a company that provides Bifendate active pharmaceutical ingredient (API) or Bifendate finished formulations upon request. The Bifendate suppliers may include Bifendate API manufacturers, exporters, distributors and traders.
click here to find a list of Bifendate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Bifendate Drug Master File in Korea (Bifendate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Bifendate. The MFDS reviews the Bifendate KDMF as part of the drug registration process and uses the information provided in the Bifendate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Bifendate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Bifendate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Bifendate suppliers with KDMF on PharmaCompass.
Bifendate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bifendate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bifendate GMP manufacturer or Bifendate GMP API supplier for your needs.
A Bifendate CoA (Certificate of Analysis) is a formal document that attests to Bifendate's compliance with Bifendate specifications and serves as a tool for batch-level quality control.
Bifendate CoA mostly includes findings from lab analyses of a specific batch. For each Bifendate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bifendate may be tested according to a variety of international standards, such as European Pharmacopoeia (Bifendate EP), Bifendate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bifendate USP).
LOOKING FOR A SUPPLIER?
